Journal Logo

Publication Only: Myelodysplastic syndromes – Clinical

PB2080 ROLE OF SOMATIC MUTATIONS IN PATIENTS WITH HIGH-RISK MYELODISPLASTIC SYNDROMES TREATED WITH INTENSIVE CHEMOTHERAPY

Caballero, J. C.1; Sánchez, J. M. Hernández2; Abáigar, M.2; Cadenas, F. López3; Janusz, K.2; Izquierdo, M. Martín2; Robledo, C.2; Ramos, F.4; Chillón, C.5; Sierra, M.6; Dávila, J.7; Cuello, R.1; De Cabo, E.8; Zato, E.9; Rivas, J. M. Hernández2,3; Del Cañizo, M. C.3; Campelo, M. Díez3

Author Information
doi: 10.1097/01.HS9.0000566804.15739.96
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.